Stockreport

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF Delivers $6.1 Million Q2 Revenue and Announces Strategic Plan to Reshape Biotech and AI-Driven Drug Discovery VICTORIA, British Columbia--(BUSINESS WIRE)--IMMUNOPRECI [Read more]